Form 8-K - Current report:
SEC Accession No. 0001437749-25-022877
Filing Date
2025-07-17
Accepted
2025-07-17 08:05:13
Documents
37
Period of Report
2025-07-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20250716_8k.htm   iXBRL 8-K 27707
2 EXHIBIT 99.1 ex_839667.htm EX-99.1 32825
3 EXHIBIT 99.2 ex_839668.htm EX-99.2 13671
8 b08.jpg GRAPHIC 70121
9 diamedicalogo.jpg GRAPHIC 6910
10 slide01.jpg GRAPHIC 113743
11 slide02.jpg GRAPHIC 127317
12 slide03.jpg GRAPHIC 124448
13 slide04.jpg GRAPHIC 72080
14 slide05.jpg GRAPHIC 100814
15 slide06.jpg GRAPHIC 90787
16 slide07.jpg GRAPHIC 75049
17 slide09.jpg GRAPHIC 59205
18 slide10.jpg GRAPHIC 92434
19 slide11.jpg GRAPHIC 83312
20 slide12.jpg GRAPHIC 81157
21 slide13.jpg GRAPHIC 78453
22 slide14.jpg GRAPHIC 86410
23 slide15.jpg GRAPHIC 81081
24 slide16.jpg GRAPHIC 88734
25 slide17.jpg GRAPHIC 80915
26 slide18.jpg GRAPHIC 69726
27 slide19.jpg GRAPHIC 96181
28 slide20.jpg GRAPHIC 79415
29 slide21.jpg GRAPHIC 76449
  Complete submission text file 0001437749-25-022877.txt   2733823

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dmac-20250717.xsd EX-101.SCH 3579
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20250717_def.xml EX-101.DEF 11029
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20250717_lab.xml EX-101.LAB 14742
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20250717_pre.xml EX-101.PRE 11134
40 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20250716_8k_htm.xml XML 2742
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 251128860
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)